We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Emerging Companies and Venture Capital

New products and ideas require capital. Cash to grow. You look for an edge on investments and deals. Lawyers on the emerging companies and venture capital team at Hogan Lovells have advised on cutting-edge start-up/venture projects that have set precedents. Our global experience in cross-border transactions attracts clients with international vision. 



Our relationship with you covers the lifecycle from start-up, early, middle, and later stage venture capital investments. We also cover the exit, which may be a sale or an IPO or run as a "dual track" exit. We also help with your general corporate needs including M&A, regulatory, and corporate governance. Immersed in technology, including biotech, financial technology, and clean technology, our team guides you through the start-up maze with confidence.

Practices

Representative experience

We advised CommerzVentures GmbH, Acton GmbH & Co. Heureka II KG, Capnamic United Venture Fund I GmbH & Co. KG on a venture capital investment in Plan Forward.

We advised Springlane GmbH on its Series C financing round with TriPos, KfW, HV Ventures, Tengelmann, and others.

We advised ABS Capital Partners on its US$20.5m investment in a premier sustainable products brand, Bambeco.

We advised Five Prime Therapeutics on a US$84.3m public offering of common stock.

Loading data